Titre : Protéines angiostatiques

Protéines angiostatiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Models, Educational
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Protéines angiostatiques : Questions médicales les plus fréquentes", "headline": "Protéines angiostatiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Protéines angiostatiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-11", "dateModified": "2025-05-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Protéines angiostatiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines angiogéniques", "url": "https://questionsmedicales.fr/mesh/D042501", "about": { "@type": "MedicalCondition", "name": "Protéines angiogéniques", "code": { "@type": "MedicalCode", "code": "D042501", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.100" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Angiostatines", "alternateName": "Angiostatins", "url": "https://questionsmedicales.fr/mesh/D043168", "about": { "@type": "MedicalCondition", "name": "Angiostatines", "code": { "@type": "MedicalCode", "code": "D043168", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.100.450.500" } } }, { "@type": "MedicalWebPage", "name": "Endostatines", "alternateName": "Endostatins", "url": "https://questionsmedicales.fr/mesh/D043169", "about": { "@type": "MedicalCondition", "name": "Endostatines", "code": { "@type": "MedicalCode", "code": "D043169", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.529.100.450.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Protéines angiostatiques", "alternateName": "Angiostatic Proteins", "code": { "@type": "MedicalCode", "code": "D043165", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Carolyn G Chen", "url": "https://questionsmedicales.fr/author/Carolyn%20G%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Anatomy, and Cell Biology and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107." } }, { "@type": "Person", "name": "Renato V Iozzo", "url": "https://questionsmedicales.fr/author/Renato%20V%20Iozzo", "affiliation": { "@type": "Organization", "name": "Department of Pathology, Anatomy, and Cell Biology and the Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania 19107 renato.iozzo@jefferson.edu." } }, { "@type": "Person", "name": "Catherine E Simpson", "url": "https://questionsmedicales.fr/author/Catherine%20E%20Simpson", "affiliation": { "@type": "Organization", "name": "Dept of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Megan Griffiths", "url": "https://questionsmedicales.fr/author/Megan%20Griffiths", "affiliation": { "@type": "Organization", "name": "Dept of Pediatrics, Division of Pediatric Cardiology, Johns Hopkins University, Baltimore, MD, USA." } }, { "@type": "Person", "name": "Jun Yang", "url": "https://questionsmedicales.fr/author/Jun%20Yang", "affiliation": { "@type": "Organization", "name": "Dept of Pediatrics, Division of Pediatric Cardiology, Johns Hopkins University, Baltimore, MD, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "From clinical data management to clinical data science: Time for a new educational model.", "datePublished": "2023-05-24", "url": "https://questionsmedicales.fr/article/37587756", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cts.13545" } }, { "@type": "ScholarlyArticle", "name": "A pedagogical model to enhance nurses' ability to support patient learning: an educational design research study.", "datePublished": "2022-07-29", "url": "https://questionsmedicales.fr/article/35909338", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5116/ijme.62c2.b9c4" } }, { "@type": "ScholarlyArticle", "name": "Preceptor Development: Using the American Nurses Credentialing Center Outcome-Based Continuing Education Model", "datePublished": "2024-05-01", "url": "https://questionsmedicales.fr/article/38687099", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3928/00220124-20240411-02" } }, { "@type": "ScholarlyArticle", "name": "Applying educational theory to medical education research.", "datePublished": "2022-07-27", "url": "https://questionsmedicales.fr/article/35656791", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/ced.15287" } }, { "@type": "ScholarlyArticle", "name": "Rolling e-learning: an educational model to support Italian healthcare professionals during the COVID-19 pandemic.", "datePublished": "2023-08-30", "url": "https://questionsmedicales.fr/article/37695199", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.23750/abm.v94iS3.14204" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Protéines et peptides de signalisation intercellulaire", "item": "https://questionsmedicales.fr/mesh/D036341" }, { "@type": "ListItem", "position": 4, "name": "Protéines angiogéniques", "item": "https://questionsmedicales.fr/mesh/D042501" }, { "@type": "ListItem", "position": 5, "name": "Protéines angiostatiques", "item": "https://questionsmedicales.fr/mesh/D043165" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Protéines angiostatiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Protéines angiostatiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-19", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Protéines angiostatiques", "description": "Comment diagnostiquer une dysrégulation angiostatique ?\nQuels examens sont utilisés pour évaluer les protéines angiostatiques ?\nLes imageries médicales aident-elles au diagnostic ?\nQuels marqueurs biologiques sont associés aux protéines angiostatiques ?\nPeut-on détecter les protéines angiostatiques dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Models,+Educational&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Protéines angiostatiques", "description": "Quels symptômes indiquent une dysfonction angiostatique ?\nLes troubles de la vision sont-ils liés aux protéines angiostatiques ?\nComment les protéines angiostatiques affectent-elles la peau ?\nY a-t-il des symptômes systémiques associés ?\nLes douleurs articulaires peuvent-elles être liées ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Models,+Educational&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Protéines angiostatiques", "description": "Comment prévenir les troubles liés aux protéines angiostatiques ?\nL'exercice physique aide-t-il à prévenir ces troubles ?\nY a-t-il des aliments à privilégier ?\nLe tabagisme influence-t-il la santé angiostatique ?\nLe stress a-t-il un impact sur l'angiogenèse ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Models,+Educational&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Protéines angiostatiques", "description": "Quels traitements ciblent les protéines angiostatiques ?\nLes traitements sont-ils efficaces contre le cancer ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements sont-ils personnalisés ?\nDes thérapies complémentaires sont-elles recommandées ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Models,+Educational&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Protéines angiostatiques", "description": "Quelles complications peuvent survenir avec une dysrégulation ?\nLes maladies cardiovasculaires sont-elles liées ?\nY a-t-il un lien avec les maladies rénales ?\nLes complications neurologiques sont-elles possibles ?\nComment les complications affectent-elles la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Models,+Educational&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Protéines angiostatiques", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe diabète est-il un facteur de risque ?\nLe mode de vie sédentaire est-il un risque ?", "url": "https://questionsmedicales.fr/mesh/D043165?mesh_terms=Models,+Educational&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysrégulation angiostatique ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des biopsies peuvent aider à évaluer l'angiogenèse." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les protéines angiostatiques ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'immunohistochimie et les dosages ELISA sont couramment utilisés." } }, { "@type": "Question", "name": "Les imageries médicales aident-elles au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'IRM et l'échographie peuvent visualiser les anomalies vasculaires." } }, { "@type": "Question", "name": "Quels marqueurs biologiques sont associés aux protéines angiostatiques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme le VEGF et l'angiostatine sont souvent mesurés." } }, { "@type": "Question", "name": "Peut-on détecter les protéines angiostatiques dans le sang ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines protéines peuvent être quantifiées dans le sérum." } }, { "@type": "Question", "name": "Quels symptômes indiquent une dysfonction angiostatique ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des douleurs, des œdèmes ou des troubles de la circulation peuvent apparaître." } }, { "@type": "Question", "name": "Les troubles de la vision sont-ils liés aux protéines angiostatiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une angiogenèse anormale peut causer des troubles visuels." } }, { "@type": "Question", "name": "Comment les protéines angiostatiques affectent-elles la peau ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent provoquer des lésions cutanées dues à une circulation sanguine altérée." } }, { "@type": "Question", "name": "Y a-t-il des symptômes systémiques associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fatigue ou la fièvre peuvent survenir dans certains cas." } }, { "@type": "Question", "name": "Les douleurs articulaires peuvent-elles être liées ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise circulation peut entraîner des douleurs articulaires." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés aux protéines angiostatiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée, est recommandé." } }, { "@type": "Question", "name": "L'exercice physique aide-t-il à prévenir ces troubles ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé vasculaire." } }, { "@type": "Question", "name": "Y a-t-il des aliments à privilégier ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des aliments riches en antioxydants, comme les fruits et légumes, sont bénéfiques." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il la santé angiostatique ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme nuit à la circulation et favorise les troubles angiostatiques." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur l'angiogenèse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut perturber l'équilibre angiostatique." } }, { "@type": "Question", "name": "Quels traitements ciblent les protéines angiostatiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des médicaments anti-angiogéniques sont utilisés." } }, { "@type": "Question", "name": "Les traitements sont-ils efficaces contre le cancer ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les inhibiteurs de l'angiogenèse sont utilisés dans certains cancers." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets comme l'hypertension ou des saignements peuvent survenir." } }, { "@type": "Question", "name": "Les traitements sont-ils personnalisés ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent être adaptés selon le type de cancer et le patient." } }, { "@type": "Question", "name": "Des thérapies complémentaires sont-elles recommandées ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des approches comme l'acupuncture peuvent être envisagées en complément." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une dysrégulation ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme des thromboses ou des hémorragies peuvent se produire." } }, { "@type": "Question", "name": "Les maladies cardiovasculaires sont-elles liées ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une mauvaise régulation angiostatique peut augmenter le risque cardiovasculaire." } }, { "@type": "Question", "name": "Y a-t-il un lien avec les maladies rénales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles angiostatiques peuvent affecter la fonction rénale." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles possibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles de la circulation peuvent entraîner des complications neurologiques." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent réduire la qualité de vie en limitant les activités quotidiennes." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité, le tabagisme et l'hypertension sont des facteurs de risque majeurs." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge en raison de la dégradation vasculaire." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies vasculaires augmentent le risque." } }, { "@type": "Question", "name": "Le diabète est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut altérer la régulation angiostatique et augmenter les complications." } }, { "@type": "Question", "name": "Le mode de vie sédentaire est-il un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire contribue à une mauvaise santé vasculaire." } } ] } ] }

Sources (10000 au total)

A pedagogical model to enhance nurses' ability to support patient learning: an educational design research study.

To design, apply, evaluate, and analyse a pedagogical model to enhance nurses' ability to create pedagogical encounters to support patients' learning.... The study relies on an educational design research approach. A pedagogical model based on learning theories was designed, applied, evaluated, and analysed in a specialist nursing programme in cancer c... The most appreciated learning activities were to study learning theories, observe pedagogical encounters, act as a critical friend, and document one's own pedagogical encounters. The written assignmen... The theoretical analysis of the evaluation identified strengths and needs for further development. The strengths tend to be the ongoing learning process created by learning activities supporting stude...

Rolling e-learning: an educational model to support Italian healthcare professionals during the COVID-19 pandemic.

Rolling reviews have been widely used by the scientific community during the COVID-19 pandemic to provide guidelines and identify potential treatments in such a quickly evolving emergency. Throughout ... We launched five main courses on COVID-19 - with focus on treatments and vaccines - from February 2020 to December 2022. For each course, we collected and analised participation data and, via question... From 22 February 2020 to 31 December 2022, a total of 224,459 enrollments were registered over the five courses with 192,966 passes (86%), for which Continuing Medical Education (CME) credits were awa... Italian healthcare professionals working during the pandemic overwhelmingly appreciated and valued the rolling e-learning offer aimed at widening the dissemination of the best practices on COVID-19. T...

Advancing a new model of collaborative practice: a decade of Whole Health interprofessional education across Veterans Health Administration.

Large-scale implementation of interprofessional education across the United States Veterans Health Administration has supported advancement of a new model of collaborative practice, the Whole Health S...

Launching an innovative educational model addressing substance use disorders and dental pain management (Project ECHO® in dentistry).

Uninformed opioid prescribing by dentists has contributed to the current opioid crisis. This report describes the development and implementation of an innovative, interactive, multidisciplinary, and p... An interdisciplinary panel of experts in medicine, pharmacy, social work, and dentistry designed and led the "Pain Management and Substance Use Disorders Dental ECHO" for invited dental care providers... The participants (N = 151) were dentists (n = 109), dental faculty (n = 15), dental residents (n = 6), dental hygienists/assistants (n = 13) and nurses and clinic administrators (n = 8). Self-reported... The Project ECHO model is effective in rapidly disseminating evidence-based information. Dentists viewed this model as having a high degree of benefit for the optimal management of dental pain and the...

The effects of a blended learning model on the physical fitness of Chinese university students: a cluster randomized controlled trial in basketball education.

The university period is a critical stage of personal development, and improving the physical fitness of university students is crucial to their academic performance, quality of life, and future. Howe... A total of 78 first-year students from a public university in Henan Province were recruited for this study via a cluster randomized controlled trial (CRCT) design. The participants were divided into a... Both learning models significantly improved students' physical fitness after 16 weeks. However, the blended learning model resulted in more significant improvements in lung capacity, sit and reach, pu... The 16-week blended learning model effectively promoted physical fitness among university students, especially in terms of their lung capacity, flexibility, strength and speed....